Literature DB >> 24387670

Biological characteristics of human-urine-derived stem cells: potential for cell-based therapy in neurology.

Jun-Jie Guan1, Xin Niu, Fei-Xiang Gong, Bin Hu, Shang-Chun Guo, Yuan-Lei Lou, Chang-Qing Zhang, Zhi-Feng Deng, Yang Wang.   

Abstract

Stem cells in human urine have gained attention in recent years; however, urine-derived stem cells (USCs) are far from being well elucidated. In this study, we compared the biological characteristics of USCs with adipose-derived stem cells (ASCs) and investigated whether USCs could serve as a potential cell source for neural tissue engineering. USCs were isolated from voided urine with a modified culture medium. Through a series of experiments, we examined the growth rate, surface antigens, and differentiation potential of USCs, and compared them with ASCs. USCs showed robust proliferation ability. After serial propagation, USCs retained normal karyotypes. Cell surface antigen expression of USCs was similar to ASCs. With lineage-specific induction factors, USCs could differentiate toward the osteogenic, chondrogenic, adipogenic, and neurogenic lineages. To assess the ability of USCs to survive, differentiate, and migrate, they were seeded onto hydrogel scaffold and transplanted into rat brain. The results showed that USCs were able to survive in the lesion site, migrate to other areas, and express proteins that were associated with neural phenotypes. The results of our study demonstrate that USCs possess similar biological characteristics with ASCs and have multilineage differentiation potential. Moreover USCs can differentiate to neuron-like cells in rat brain. The present study shows that USCs are a promising cell source for tissue engineering and regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24387670      PMCID: PMC4086681          DOI: 10.1089/ten.TEA.2013.0584

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   4.080


  33 in total

1.  Generation of CD133+ cells from CD133- peripheral blood mononuclear cells and their properties.

Authors:  Erik J Suuronen; Serena Wong; Varun Kapila; Geeta Waghray; Stewart C Whitman; Thierry G Mesana; Marc Ruel
Journal:  Cardiovasc Res       Date:  2006-03-10       Impact factor: 10.787

Review 2.  Mesenchymal stromal cells from umbilical cord blood.

Authors:  Karen Bieback; Harald Klüter
Journal:  Curr Stem Cell Res Ther       Date:  2007-12       Impact factor: 3.828

Review 3.  Neural tissue engineering of the CNS using hydrogels.

Authors:  David R Nisbet; Kylie E Crompton; Malcolm K Horne; David I Finkelstein; John S Forsythe
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2008-10       Impact factor: 3.368

4.  Delivery of adipose-derived precursor cells for peripheral nerve repair.

Authors:  Lizzie Y Santiago; Julio Clavijo-Alvarez; Candace Brayfield; J Peter Rubin; Kacey G Marra
Journal:  Cell Transplant       Date:  2009       Impact factor: 4.064

5.  Photocrosslinkable chitosan based hydrogels for neural tissue engineering.

Authors:  Chandra M Valmikinathan; Vivek J Mukhatyar; Anjana Jain; Lohitash Karumbaiah; Madhuri Dasari; Ravi V Bellamkonda
Journal:  Soft Matter       Date:  2011-12-23       Impact factor: 3.679

6.  The adipose-derived stem cell: looking back and looking ahead.

Authors:  Patricia A Zuk
Journal:  Mol Biol Cell       Date:  2010-04-07       Impact factor: 4.138

7.  Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors.

Authors:  Guihua Liu; Rajesh A Pareta; Rongpei Wu; Yingai Shi; Xiaobo Zhou; Hong Liu; Chunhua Deng; Xiangzhou Sun; Anthony Atala; Emmanuel C Opara; Yuanyuan Zhang
Journal:  Biomaterials       Date:  2012-11-06       Impact factor: 12.479

8.  Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering.

Authors:  Shaofeng Wu; Yan Liu; Shantaram Bharadwaj; Anthony Atala; Yuanyuan Zhang
Journal:  Biomaterials       Date:  2010-11-04       Impact factor: 15.304

9.  Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours.

Authors:  Ren Lang; Guihua Liu; Yingai Shi; Shantaram Bharadwaj; Xiaoyan Leng; Xiaobo Zhou; Hong Liu; Anthony Atala; Yuanyuan Zhang
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

10.  Self-assembling peptide nanofiber scaffolds accelerate wound healing.

Authors:  Aurore Schneider; Jonathan A Garlick; Christophe Egles
Journal:  PLoS One       Date:  2008-01-09       Impact factor: 3.240

View more
  38 in total

1.  Effects of the donor age on proliferation, senescence and osteogenic capacity of human urine-derived stem cells.

Authors:  Peng Gao; Peilin Han; Dapeng Jiang; Shulong Yang; Qingbo Cui; Zhaozhu Li
Journal:  Cytotechnology       Date:  2017-04-13       Impact factor: 2.058

Review 2.  Virus integration and genome influence in approaches to stem cell based therapy for andro-urology.

Authors:  Longkun Li; Deying Zhang; Peng Li; Margot Damaser; Yuanyuan Zhang
Journal:  Adv Drug Deliv Rev       Date:  2014-10-18       Impact factor: 15.470

3.  Human urine-derived stem cells play a novel role in the treatment of STZ-induced diabetic mice.

Authors:  Tianxue Zhao; Deng Luo; Yun Sun; Xin Niu; Yang Wang; Chen Wang; Weiping Jia
Journal:  J Mol Histol       Date:  2018-04-19       Impact factor: 2.611

Review 4.  Urine-derived stem cells: applications in skin, bone and articular cartilage repair.

Authors:  Wenqian Zhang; Jungen Hu; Yizhou Huang; Chenyu Wu; Huiqi Xie
Journal:  Burns Trauma       Date:  2021-11-26

5.  Exosomal lncRNA TUG1 derived from human urine-derived stem cells attenuates renal ischemia/reperfusion injury by interacting with SRSF1 to regulate ASCL4-mediated ferroptosis.

Authors:  Zejia Sun; Jiyue Wu; Qing Bi; Wei Wang
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

6.  Effects of human urine-derived stem cells on the cementogenic differentiation of indirectly-cocultured periodontal ligament stem cells.

Authors:  Xiao Yang; Xue Xiong; Wenwen Zhou; Gang Feng; Yuanyuan Zhang; Hongwei Dai; Jianping Zhou
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

7.  Induced pluripotent stem cell-derived mesenchymal stem cells deliver exogenous miR-105-5p via small extracellular vesicles to rejuvenate senescent nucleus pulposus cells and attenuate intervertebral disc degeneration.

Authors:  Yongjin Sun; Wenzhi Zhang; Xu Li
Journal:  Stem Cell Res Ther       Date:  2021-05-13       Impact factor: 6.832

8.  Design and Validation of a Process Based on Cationic Niosomes for Gene Delivery into Novel Urine-Derived Mesenchymal Stem Cells.

Authors:  Yerai Vado; Gustavo Puras; Melania Rosique; Cesar Martin; Jose Luis Pedraz; Shifa Jebari-Benslaiman; Marian M de Pancorbo; Jon Zarate; Guiomar Perez de Nanclares
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

9.  ATF5, a putative therapeutic target for the mitochondrial DNA 3243A > G mutation-related disease.

Authors:  Xinpei Gao; Zhixin Jiang; Xinfeng Yan; Jiping Liu; Fengwen Li; Peng Liu; Jialu Li; Yuehua Wei; Yi Eve Sun; Yinan Zhang; Congrong Wang
Journal:  Cell Death Dis       Date:  2021-07-14       Impact factor: 8.469

Review 10.  Creating stem cell-derived neuromuscular junctions in vitro.

Authors:  Shawn M Luttrell; Alec S T Smith; David L Mack
Journal:  Muscle Nerve       Date:  2021-07-30       Impact factor: 3.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.